Genetic testing strategies for neonatal cholestasis in the neonatal intensive care unit
Journal of Pediatric Gastroenterology and Nutrition · 17.11.2026
DOI: 10.1002/jpn3.70696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 17.11.2026. Verfasst von Alyshah Lakhani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Nationwide Children's Hospital, Columbus, Ohio, USA. Die Arbeit nennt 23 Literaturangaben. Gefördert von: None.
Themen: Neonatologie, Intensivpflege
Abstract (Originalsprache)
Objectives
Cholestasis in the Neonatal Intensive Care Unit (NICU) has a broad differential diagnosis, including genetic diseases. Advances in next generation sequencing (NGS) have expanded the ability to identify genetic etiologies. Studies evaluating testing strategies, diagnostic yield, and clinical characteristics of those undergoing genetic testing for cholestasis in the NICU are limited.
Methods
We retrospectively studied patients at a single‐center Level IV NICU with cholestasis, genetic testing and Hepatology consultation between January 1, 2015, and December 31, 2024. Microarray, targeted gene panel and exome or genome sequencing (ES/GS) results and clinical characteristics of those tested were reviewed. Diagnostic yield was defined as identification of pathogenic variants determined to be causative of cholestasis. Categorical variables were compared using Chi‐squared test or Fisher's exact as appropriate. Continuous variables were compared using Wilcoxon rank sum tests or Kruskal–Wallis tests as appropriate.
Results
A total of 174 patients were included for analysis. Patients with three modalities of testing had higher peak direct bilirubin and alanine aminotransferase. Diagnostic yield increased by comprehensiveness: microarray 5% (3/54), targeted gene panel 10% (12/125) and ES/GS 33% (23/70). Seven patients with non‐diagnostic targeted panels had diagnostic ES/GS. Those with diagnostic ES/GS were younger at Hepatology consultation, had higher peak direct bilirubin and were less likely to have sepsis compared to those with diagnostic targeted panels.
Conclusions
ES/GS demonstrated greater diagnostic yield for cholestasis in the NICU than other modalities. Confounding by year of testing is possible, but differences in yield support preferential use of ES/GS for neonatal cholestasis evaluation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Nationwide Children's Hospital, Columbus, Ohio, USA.
- Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, Ohio, USA.
- Department of Pediatrics, The Ohio State College of Medicine, Columbus, Ohio, USA.
- Division of Genetic and Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
ORCID-Profile: Alyshah Lakhani, Alexander Weymann, Bimal P Chaudhari, A Jay Freeman
Förderung
- None
Zitieren
APA
Lakhani, A., Joshi, S., Balster, S., Weymann, A., Potter, C. J., Chaudhari, B. P., & Freeman, A. J. (2026). Genetic testing strategies for neonatal cholestasis in the neonatal intensive care unit. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70696
Vancouver
Lakhani A, Joshi S, Balster S, Weymann A, Potter CJ, Chaudhari BP, et al. Genetic testing strategies for neonatal cholestasis in the neonatal intensive care unit. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70696
BibTeX
@article{Lakhani2026,
author = {Lakhani, Alyshah and Joshi, Shivam and Balster, Sarah and Weymann, Alexander and Potter, Carol J and Chaudhari, Bimal P and Freeman, A Jay},
title = {Genetic testing strategies for neonatal cholestasis in the neonatal intensive care unit},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70696}
}
EUVIMED